Kelman Lazarov, Inc. Merck & Co., Inc. Transaction History
Kelman Lazarov, Inc.
- $494 Million
- Q2 2024
A detailed history of Kelman Lazarov, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kelman Lazarov, Inc. holds 2,054 shares of MRK stock, worth $225,467. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,054
Previous 2,496
17.71%
Holding current value
$225,467
Previous $329,000
22.8%
% of portfolio
0.05%
Previous 0.07%
Shares
17 transactions
Others Institutions Holding MRK
# of Institutions
3,826Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$26.9 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$22.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12.9 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.96 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.26 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $278B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...